Metrics to compare | EIQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEIQPeersSector | |
|---|---|---|---|---|
P/E Ratio | −25.5x | −2.9x | 12.0x | |
PEG Ratio | 1.00 | −0.02 | 0.01 | |
Price/Book | 40.8x | 1.6x | 2.4x | |
Price / LTM Sales | 5,152.9x | 1.3x | 2.3x | |
Upside (Analyst Target) | 42.6% | 54.6% | 33.4% | |
Fair Value Upside | Unlock | 24.0% | 4.0% | Unlock |
Echo IQ Limited, an artificial intelligence (AI) and medical technology company, engages in the development and application of AI for the cardiac diagnostics sector in Australia. It offers EchoSolv, a machine-learning and AI-based clinical decision support software for use as an adjunct to echocardiography in the assessment of severe aortic stenosis and other cardiovascular conditions. The company has a research collaboration with Mayo Clinic to assess cardiac risk in patients receiving cancer therapy. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.